Thursday, April 20, 2017
Atara Biotherapeutics Leases New Space In Thousand Oaks
Thousand Oaks-based Atara Biotherapeutics, which is developing treatments for patients with cancer, autoimmune and infectious disease, has leased a 90,000 square foot building in the Conejo Spectrum, according to developer SARES-REGIS Group. SARES-REGIS said the lease is the first of nine, industrial buildings it is developing at the Conejo Spectrum Business Park. SARES-REGIS did not say how much the 15-year lease was worth, but said the building is the second largest in its project. Atara is venture backed by Alexandria Venture Investments, Amgen Ventures, The Baupost Group, Celgene Corporation, DAG Ventures, Domain Associates, EcoR1 Capital and Kleiner Perkins Caufield & Byers.